| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/21/1997 | EP0774000A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 05/21/1997 | EP0773999A2 Or-1 on orphan receptor belonging to the nuclear receptor family |
| 05/21/1997 | EP0773998A1 Novel vesicular acetylcholine carrier |
| 05/21/1997 | EP0773997A2 Htk ligand |
| 05/21/1997 | EP0773996A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 05/21/1997 | EP0773995A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof |
| 05/21/1997 | EP0773994A1 Receptor-ligand assay |
| 05/21/1997 | EP0773993A1 Genetically engineered swine cells |
| 05/21/1997 | EP0773992A1 Transgenically produced antithrombin iii |
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773961A1 Separation of human serum albumin |
| 05/21/1997 | EP0773960A1 POLYPEPTIDES WITH Fc BINDING ABILITY |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773958A1 PTH OR PTHrP ANTAGONISTS |
| 05/21/1997 | EP0773957A2 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 05/21/1997 | EP0773952A1 Interaction trap systems for detecting protein interactions |
| 05/21/1997 | EP0773950A1 Linked peptide nucleic acids |
| 05/21/1997 | EP0773790A1 Invariant chain compositions useful for treating autoimmune diseases |
| 05/21/1997 | EP0773789A1 Pharmaceutical compositions containing extracted mhc molecules, for stimulation of the immune system |
| 05/21/1997 | EP0773787A1 HLA binding peptides and their uses |
| 05/21/1997 | EP0684829A4 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof. |
| 05/21/1997 | EP0679187B1 Process for recovering native, oligomeric, glycosylated ectodomains of viral membrane proteins, their use, in particular as vaccine against hiv |
| 05/21/1997 | EP0658195B1 Virus obtainable from human neuroblastoma cells |
| 05/21/1997 | EP0595948B1 Yeast strains with stable integration of heterologous genes |
| 05/21/1997 | EP0527821B1 Oxidation resistant thrombomodulin analogs |
| 05/21/1997 | EP0474790B1 Media for cell growth and method for making them |
| 05/21/1997 | EP0472725B1 Treatment of polycystic ovarian disease |
| 05/21/1997 | EP0409928B1 Expression of proteinaceous sweeteners in yeast |
| 05/21/1997 | CN1150458A Hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF for hematopoietic stimulation |
| 05/21/1997 | CN1150457A Gene imparting flocculability to yeast and gene product |
| 05/21/1997 | CN1150434A Platelet growth accelerator |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150390A Glial mitogenic factors, their preparation and use |
| 05/21/1997 | CN1034943C Process for preparing cyclic vasoactive peptides |
| 05/20/1997 | US5631407 Testing the efficacy of a vaccine to determine protection from infection by human picornavirus; genetic engineering |
| 05/20/1997 | US5631360 Multistage synthesis, treatment of nucleosides, adding a n-phthaloyl group, deprotecting the hydroxy, tritylation and phosphitylation |
| 05/20/1997 | US5631358 Legume early nodulin gene; soybeans; genetic engineering |
| 05/20/1997 | US5631351 Antibodies to MDC proteins |
| 05/20/1997 | US5631350 Anti-human influenza virus antibody |
| 05/20/1997 | US5631349 Chimeric monoclonal antibodies recognizing human interleukin-2-receptor |
| 05/20/1997 | US5631348 Protein sequence of the plant toxin gelonin |
| 05/20/1997 | US5631347 Reducing gelation of a fatty acid-acylated protein |
| 05/20/1997 | US5631243 Protective lubricants for eye surgery which can easily be removed, in mixture with mucopolysaccharides |
| 05/20/1997 | US5631236 Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| 05/20/1997 | US5631230 Receptor selective analogues of cholecystokinin-8 |
| 05/20/1997 | US5631228 Anti-fungal and anti-bacterial histatin-based peptides |
| 05/20/1997 | US5631227 Somatotropin analogs |
| 05/20/1997 | US5631223 Cyclic oligopeptides |
| 05/20/1997 | US5631222 Treatment of asthma, angina pectoris, cardiovascular and brain disorders; hypotensive agents |
| 05/20/1997 | US5631221 Pollenosis-inducing polypeptide, process for preparing the same, and uses thereof |
| 05/20/1997 | US5631172 Lead assay |
| 05/20/1997 | US5631162 Gene expression and dna sequences |
| 05/20/1997 | US5631156 Genetic engineering |
| 05/20/1997 | US5631154 Polypeptides, genetic engineering and assembly of defective viral particles |
| 05/20/1997 | US5631153 Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same |
| 05/20/1997 | US5631151 Melanin production by transformed organisms |
| 05/20/1997 | US5631145 Biosynthesis, genetic engineering |
| 05/20/1997 | US5631144 Application of novel DNA fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeast and corresponding process for the preparation of proteins |
| 05/20/1997 | US5631143 K. lactis pyruvate-decarboxylase promoter and use thereof |
| 05/20/1997 | US5631142 Compositions comprising bone morphogenetic protein-2 (BMP-2) |
| 05/20/1997 | US5631133 Transition in transcriptional activation by intracellular hormone receptors at the tumor stage of dermal fibrosarcoma development |
| 05/20/1997 | US5631010 Genetically stable cholera vaccines with deletions of ctxA, recA and attRS1 |
| 05/20/1997 | US5631009 Erythrocytes and reaction with antisera and antibodies |
| 05/15/1997 | WO1997017614A1 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 05/15/1997 | WO1997017613A1 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 05/15/1997 | WO1997017470A1 Detection of mammary tumor virus-like sequences in human breast cancer |
| 05/15/1997 | WO1997017458A1 Accessory functions for use in recombinant aav virion production |
| 05/15/1997 | WO1997017456A1 In vitro construction of sv40 viruses and pseudoviruses |
| 05/15/1997 | WO1997017455A2 Commercial production of avidin in plants |
| 05/15/1997 | WO1997017453A1 Commercial production of aprotinin in plants |
| 05/15/1997 | WO1997017452A1 Blackcurrant promoters and genes |
| 05/15/1997 | WO1997017449A1 A method for expressing phosphorylated recombinant human beta-casein in a bacterial system |
| 05/15/1997 | WO1997017445A1 Method for treating neurodegenerative diseases using a 1c2 antibody or a fragment or derivative thereof, and corresponding pharmaceutical compositions |
| 05/15/1997 | WO1997017444A2 Novel sperm receptors |
| 05/15/1997 | WO1997017443A1 Huntingtin-associated protein |
| 05/15/1997 | WO1997017442A1 Flk-1 binding protein |
| 05/15/1997 | WO1997017441A1 Autoantigens |
| 05/15/1997 | WO1997017440A1 Neuropeptide y-y5 receptor |
| 05/15/1997 | WO1997017439A1 Method for expression cloning of gene encoding protein kinase substrate protein |
| 05/15/1997 | WO1997017437A2 A chromosome 21 - derived nucleic acid encoding a novel protein, compositions and method using same |
| 05/15/1997 | WO1997017436A1 Stable avidin composition and methods using same |
| 05/15/1997 | WO1997017435A1 Stable biotinylated biomolecule composition and methods |
| 05/15/1997 | WO1997017432A1 Insecticidal protein toxins from photorhabdus |
| 05/15/1997 | WO1997017431A1 Cell lines expressing an acetylcholine receptor, containing an epsilon subunit |
| 05/15/1997 | WO1997017427A1 Novel process for the propagation of b. pertussis |
| 05/15/1997 | WO1997017371A1 ISOLATION OF apo(a), COMPOSITIONS, AND METHODS OF USE |
| 05/15/1997 | WO1997017370A1 Anion exchange process for the purification of factor viii |
| 05/15/1997 | WO1997017369A2 Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector |
| 05/15/1997 | WO1997017368A1 Cd100 antigen and uses therefor |
| 05/15/1997 | WO1997017367A1 Method of grf peptides synthesis |
| 05/15/1997 | WO1997017366A1 Heparin chromatography of erythropoietins |
| 05/15/1997 | WO1997017361A1 IgG SEPARATION MEDIUM AND NOVEL PROTEIN A VARIANT |
| 05/15/1997 | WO1997017360A2 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 05/15/1997 | WO1997017359A1 Novel promoter for vegf receptor |
| 05/15/1997 | WO1997017358A1 Mammary transforming protein |
| 05/15/1997 | WO1997017090A1 Adenovirus-mediated production of bioactive proteins by mammalian cells and animals |
| 05/15/1997 | WO1997017085A2 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 05/15/1997 | WO1997013781A3 Synthetic peptides that inhibit il-6 activity |
| 05/15/1997 | WO1997012900A3 Ring finger protein |
| 05/15/1997 | WO1997011093A3 Parainfluenza virus glycoproteins and vaccines |